Three regions, one duplicate, and the renewal that keeps going through.

Federated enterprises rarely have a software problem. They have three, each with its own regional owner, its own renewal calendar, and its own set of reasons why consolidation is theoretically sensible but practically impossible. The central team knows the spend is wrong. The regions know the consolidation is coming. And the renewal keeps going through anyway.

The estate that grows by omission

A global life sciences company. Operations across every major market. The IT director knew, in his gut, the organisation was paying for the same capability three times over. The US ran Veeva Vault. Europe had settled on Documentum. The Asian operation had moved to OpenText because it satisfied local PMDA e-submission requirements.

Nobody was lying. The regional objections were real. Fifteen-year workflows, jurisdiction-specific certifications, user communities that had shaped their processes around a particular interface. That combination makes consolidation genuinely hard, not just politically inconvenient. The central team acknowledged it. They planned a workshop series. They started building a feature comparison matrix. And then the renewal window closed.

Why the central team always loses this one

The standard response to regional software overlap is a consolidation project. Chase the contract dates across three procurement systems. Pull the feature comparison together. Badger three regional IT leads for user counts. Commission an analysis of the compliance requirements against each platform.

By the time you have everything you need, the renewal has already gone through.

One region re-signed for twelve months while the workshop calendar was still being negotiated. The team notes it, flags it for next year, and the spend compounds. This is not a failure of intent. A small central team governing a sprawling estate is structurally one step behind the renewal calendar. The data arrives after the decision window has closed.

What SAM tools and SaaS platforms were never built for

SAM tools tell you what you own and whether you are compliant. They do not compare feature-level substitutability. When the US owns Tool A and the EU owns Tool B, a SAM report will not tell you whether they are functional duplicates or genuinely different capabilities.

SaaS management platforms track usage and spend. They do not explain what can replace what. Enterprise architecture systems map the technical landscape. They do not govern procurement decisions. And generic AI can answer questions about software categories. It cannot safely decide for your estate. It has no knowledge of your renewal dates, your approved vendors, your policy constraints, or your actual deployed tools. It cannot produce an audit-ready source trail. How Samplify handles this is explained on the how it works page.

The answer before the autopilot fires

The life sciences company has not consolidated yet. That remains a real project, with real change management and real regional negotiation. What changed is that they have the right answer before the renewal decision closes. They can approach regional owners with sourced evidence rather than a workshop invitation. They can negotiate the renewal. They can take a REPLACE recommendation to the CFO with a documented rationale and a source trail attached.

The annual licence is around £100k. One avoided duplicate renewal pays for it. One consolidation across three regions is a different conversation entirely.

This is what the decision layer does. Not another dashboard to train teams on. A reliable, sourced answer before the window closes, every time. If it does not deliver inside 30 days, walk away.